Dixon Hubard Feinour & Brown’s Thermo Fisher Scientific TMO Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$8.73M	Sell	16,063 -303	-2%	-$167K	1.04%	31
2022 Q1	$9.67M	Sell	16,366 -13,254	-45%	-$7.61M	0.97%	34
2021 Q4	$19.8M	Buy	29,620 +2,473	+9%	+$1.54M	1.9%	6
2021 Q3	$15.5M	Sell	27,147 -2,582	-9%	-$1.42M	3.29%	3
2021 Q2	$15M	Sell	29,729 -31,624	-52%	-$14.9M	3.12%	4
2021 Q1	$27.5M	Buy	61,353 +29,829	+95%	+$14.2M	3.39%	3
2020 Q4	$13.9M	Hold	31,524	–	–	3.57%	3
2020 Q3	$13.9M	Sell	31,524 -913	-3%	-$377K	3.57%	3
2020 Q2	$13.2M	Sell	32,437 -619	-2%	-$207K	3.43%	3
2020 Q1	$9.38M	Sell	33,056 -1,375	-4%	-$434K	3.17%	6
2019 Q4	$11.2M	Sell	34,431 -140	-0.4%	-$42.5K	2.9%	4
2019 Q3	$10.1M	Buy	34,571 +105	+0.3%	+$30.1K	2.79%	8
2019 Q2	$10.1M	Buy	34,466 +245	+0.7%	+$67.5K	2.88%	5
2019 Q1	$9.37M	Buy	34,221 +178	+0.5%	+$44.3K	2.82%	5
2018 Q4	$7.62M	Sell	34,043 -1,072	-3%	-$252K	2.82%	5
2018 Q3	$8.57M	Buy	+35,115	New	+$8.08M	2.37%	6
2016 Q4	–	Sell	-44,010	Closed	-$7M	–	185
2016 Q3	$7M	Buy	44,010 +400	+0.9%	+$61.6K	2.17%	10
2016 Q2	$6.44M	Buy	+43,610	New	+$6.44M	2.06%	13

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dixon Hubard Feinour & Brown's TMO Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2022, selling an estimated $167K and leaving 16,063 shares worth $8.73M. The position accounts for 1.04% of the portfolio, ranked #31.

Dixon Hubard Feinour & Brown first reported a position in TMO in Q2 2016 and has held it in 18 quarters since. The position peaked at $27.5M in Q1 2021. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Dixon Hubard Feinour & Brown held 16,063 shares of Thermo Fisher Scientific worth $8.73M as of Q2 2022.
Dixon Hubard Feinour & Brown sold 303 Thermo Fisher Scientific shares in Q2 2022, an estimated $167K.
Thermo Fisher Scientific made up 1.04% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #31 holding.
Dixon Hubard Feinour & Brown first reported a position in Thermo Fisher Scientific in Q2 2016 and has held it in 18 quarters since.
Dixon Hubard Feinour & Brown's Thermo Fisher Scientific position peaked at $27.5M in Q1 2021.
2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.